Clinical trial
REBEAT Resynchronisation and Beta-Blocker European Trial
NCT00305526 · Guidant Corporation, Industry · Terminated
Key facts
| NCT number | NCT00305526 |
|---|---|
| Title | REBEAT Resynchronisation and Beta-Blocker European Trial |
| Official title | Resynchronisation and Beta-Blocker European Trial |
| Lead sponsor | Guidant Corporation, Industry |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Heart Failure |
| Intervention type | Device |
| Interventions | Contak Renewal (CRT-D) |
| Enrollment | 354 |
| Start date | Apr 1, 2006 |
| Completion | Jul 1, 2007 |
| First posted | Mar 22, 2006 |
| Last update posted | Aug 9, 2007 |
| Countries | Italy, Switzerland |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: